-temps. Sous la responsabilité du chef de service, vous aurez pour principales missions : Rencontre et suivi médical des... de la situation médicale et de connaître au mieux les antécédents et problèmes de chacun, Assurer le suivi médical des personnes...
: Rencontre et suivi médical des personnes hébergées : Rencontrer chaque personne accueillie au sein de l'établissement afin... suivi médical des personnes accueillies de manière constante et prioritaire et veiller au maximum à leur autonomie, Tenir...
Walter Learning conçoit, produit et diffuse des formations en ligne à destination des professionnels, sous plusieurs marques : Walter Learning : formations généralistes (HACCP, bureautique, web & digital, etc.) et formations longues (CAP......
et Koungou. Tous les sites sont équipés de tout le matériel médical nécessaire au bon fonctionnement de l’activité. Il s'agit... examens et du traitement et leur prodigue des conseils d’éducation thérapeutique ·Assurer le suivi médical des patients...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »